×
Entrez Id:
6041
Gene Symbol:
RNASEL
RNASEL
Prostate cancer, familial
0.700
SusceptibilityMutation
ORPHANET
Many polymorphisms in genes, such as ELAC2 (locus HPC2), RNase L (locus hereditary prostate cancer 1 gene [HPC1]), and MSR1 have been recognized as important genetic factors that confer an increased risk of developing prostate cancer in many populations.
23141781
2013
×
Entrez Id:
60528
Gene Symbol:
ELAC2
ELAC2
Prostate cancer, familial
0.600
SusceptibilityMutation
ORPHANET
Many polymorphisms in genes, such as ELAC2 (locus HPC2 ), RNase L (locus hereditary prostate cancer 1 gene [HPC1]), and MSR1 have been recognized as important genetic factors that confer an increased risk of developing prostate cancer in many populations.
23141781
2013
×
Entrez Id:
10481
Gene Symbol:
HOXB13
HOXB13
Prostate cancer, familial
0.600
SusceptibilityMutation
ORPHANET
The novel HOXB13 G84E variant is associated with a significantly increased risk of hereditary prostate cancer .
22236224
2012
×
Entrez Id:
4481
Gene Symbol:
MSR1
MSR1
Prostate cancer, familial
0.580
SusceptibilityMutation
ORPHANET
Many polymorphisms in genes, such as ELAC2 (locus HPC2), RNase L (locus hereditary prostate cancer 1 gene [HPC1]), and MSR1 have been recognized as important genetic factors that confer an increased risk of developing prostate cancer in many populations.
23141781
2013
×
Entrez Id:
4481
Gene Symbol:
MSR1
MSR1
Prostate cancer, familial
0.580
SusceptibilityMutation
ORPHANET
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
12244320
2002
×
Entrez Id:
11200
Gene Symbol:
CHEK2
CHEK2
Prostate cancer, familial
0.520
SusceptibilityMutation
ORPHANET
Additional screening for CHEK2 mutations in 149 families with familial prostate cancer revealed 11 mutations (5 unique) in nine families.
12533788
2003
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
Prostate cancer, familial
0.380
SusceptibilityMutation
ORPHANET
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
17700570
2007
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
Prostate cancer, familial
0.360
SusceptibilityMutation
ORPHANET
Prostate cancer: germline prediction for a commonly variable malignancy.
22974436
2012
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
Prostate cancer, familial
0.360
SusceptibilityMutation
ORPHANET
Cancer Incidence in BRCA1 mutation carriers.
12237281
2002
×
Entrez Id:
4477
Gene Symbol:
MSMB
MSMB
Prostate cancer, familial
0.320
SusceptibilityMutation
ORPHANET
Mutation analysis of the MSMB gene in familial prostate cancer .
19997100
2010
×
Entrez Id:
4477
Gene Symbol:
MSMB
MSMB
Prostate cancer, familial
0.320
SusceptibilityMutation
ORPHANET
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
19383797
2009
×
Entrez Id:
4477
Gene Symbol:
MSMB
MSMB
Prostate cancer, familial
0.320
SusceptibilityMutation
ORPHANET
Multiple newly identified loci associated with prostate cancer susceptibility.
18264097
2008
×
Entrez Id:
4683
Gene Symbol:
NBN
NBN
Prostate cancer, familial
0.310
SusceptibilityMutation
ORPHANET
In this study, 94 unrelated familial prostate cancer cases from the University of Michigan Prostate Cancer Genetics Project (n = 54) and Johns Hopkins University (n = 40) were subjected to targeted next-generation sequencing of the exons, including UTRs, of NBN .
22864661
2012
×
Entrez Id:
2048
Gene Symbol:
EPHB2
EPHB2
Prostate cancer, familial
0.310
SusceptibilityMutation
ORPHANET
A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.
16155194
2006
×
Entrez Id:
4683
Gene Symbol:
NBN
NBN
Prostate cancer, familial
0.310
SusceptibilityMutation
ORPHANET
NBS1 is a prostate cancer susceptibility gene.
14973119
2004
×
Entrez Id:
6716
Gene Symbol:
SRD5A2
SRD5A2
Prostate cancer, familial
0.310
GeneticVariation
ORPHANET
×
Entrez Id:
6928
Gene Symbol:
HNF1B
HNF1B
Prostate cancer, familial
0.300
SusceptibilityMutation
ORPHANET
Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.
18701471
2008